Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.

Pharmaceutical

Siegfried Holding

Wolfgang Wienand

Peter Stierli

Henrik Krüpper

Irene Wosgien

Jürgen Roos

Reto Suter

Marianne Späne

Marcel Imwinkelried

The Analytical Development and Support team at Siegfried Holding focuses on enhancing the quality and efficiency of drug development through rigorous analytical methods. This multidisciplinary team is responsible for the design and validation of analytical techniques, supporting both active pharmaceutical ingredient (API) and drug product development. By collaborating closely with production and project teams, they ensure compliance with regulatory standards and facilitate the successful transition of formulations from development to manufacturing.

Analytical Development and Support

Quality Assurance and Control

Leadership Team

Analytical Development and Support

About

Team members

Other teams at Siegfried Holding

Quality Assurance and Control

Leadership Team